Brazil approves Pfizer's COVID-19 shot, but has none to use - (This is Money via NewsPoints Desk)

  • Brazil's health regulator Anvisa says it has fully approved Pfizer and BioNTech's COVID-19 vaccine, though a dispute over a supply deal means the country has none with which to start an immunization program, as reported in This is Money.

  • According to Anvisa, the Pfizer/BioNTech product is the first coronavirus vaccine to receive full approval in Brazil, while vaccines developed by AstraZeneca and Sinovac have only been approved for emergency use.

  • "We hope to be able to move forward in our negotiations with the Brazilian government to support the immunization of the country's population," commented Pfizer's Brazil chief Marta Diez, without giving further details.

To read more NewsPoints articles, click here.